Gene · 10468
Papers3,272
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,272
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers. | J Clin Med | 2024 | 38398421 | PubTator, text mining | PubMed |
| The Reign of Follistatin in Tumors and Their Microenvironment: Implications for Drug Resistance. | Biology (Basel) | 2024 | 38392348 | PubTator, text mining | PubMed |
| Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic Esophagitis. | Cell Mol Gastroenterol Hepatol | 2024 | 38340809 | PubTator, text mining | PubMed |
| Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA study. | Cardiovasc Diabetol | 2024 | 38310303 | PubTator, text mining | PubMed |
| Calotropis procera: A double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis. | Heliyon | 2024 | 38304784 | PubTator, text mining | PubMed |
| Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence. | JGH Open | 2024 | 38283070 | PubTator, text mining | PubMed |
| Insights into How Plant-Derived Extracts and Compounds Can Help in the Prevention and Treatment of Keloid Disease: Established and Emerging Therapeutic Targets. | Int J Mol Sci | 2024 | 38279232 | PubTator, text mining | PubMed |
| New Trends to Treat Muscular Atrophy: A Systematic Review of Epicatechin. | Nutrients | 2024 | 38276564 | PubTator, text mining | PubMed |
| High-Protein Diets during either Resistance or Concurrent Training Have No Detrimental Effect on Bone Parameters in Resistance-Trained Males. | Nutrients | 2024 | 38276563 | PubTator, text mining | PubMed |
| The Influence of Metabolic Syndrome on Potential Aging Biomarkers in Participants with Metabolic Syndrome Compared to Healthy Controls. | Biomedicines | 2024 | 38275413 | PubTator, text mining | PubMed |
| The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review. | Int J Mol Sci | 2024 | 38255975 | PubTator, text mining | PubMed |
| Relationships between Circulating Biomarkers and Body Composition Parameters in Patients with Metabolic Syndrome: A Community-Based Study. | Int J Mol Sci | 2024 | 38255954 | PubTator, text mining | PubMed |
Involvement of Yes-Associated Protein 1 Activation in the Matrix Degradation of Human-Induced-Pluripotent-Stem-Cell-Derived Chondrocytes Induced by T-2 Toxin and Deoxynivalenol Alone and in Combination. | Int J Mol Sci | 2024 | 38255951 | PubTator, text mining | PubMed |
| Diabetes-induced male infertility: potential mechanisms and treatment options. | Mol Med | 2024 | 38225568 | PubTator, text mining | PubMed |
| Therapeutic applications of ginseng for skeletal muscle-related disorder management. | J Ginseng Res | 2024 | 38223826 | PubTator, text mining | PubMed |
| The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy. | Neurol Ther | 2024 | 38190001 | PubTator, text mining | PubMed |
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study. | Metabolism | 2024 | 38181882 | PubTator, text mining | PubMed |
| Multiomics analysis of cultured mouse periodontal ligament cell-derived extracellular matrix. | Sci Rep | 2024 | 38172274 | PubTator, text mining | PubMed |
| Population-scale skeletal muscle single-nucleus multi-omic profiling reveals extensive context specific genetic regulation. | bioRxiv | 2024 | 38168419 | PubTator, text mining | PubMed |
| Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway. | Oncol Rep | 2024 | 38131250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10468/papers?page=9